We are live on ! Find out more
FMI

F/M Investments Portfolio holdings

AUM $1.97B
1-Year Est. Return 30.33%
This Fund
S&P 500
This Quarter Est. Return
+12.59%
1 Year Est. Return
+30.33%
3 Year Est. Return
+101.46%
5 Year Est. Return
+144.03%
10 Year Est. Return
–
AUM
$2.75B
AUM Growth
+$244M
Cap. Flow
+$1.32M
Cap. Flow %
0.05%
Top 10 Hldgs %
34.07%
Holding
425
New
34
Increased
204
Reduced
126
Closed
25

Top Buys

Rank Stock Value
1
TBIL
F/m US Treasury 3 Month Bill Fund
TBIL
+$12M
2
RBIL
F/m Ultrashort Treasury Inflation-Protected Security (TIPS) ETF
RBIL
+$9.94M
3
CMG icon
Chipotle Mexican Grill
CMG
+$8.35M
4
ISRG icon
Intuitive Surgical
ISRG
+$8.33M
5
FANG icon
Diamondback Energy
FANG
+$7.35M

Top Sells

Rank Stock Value
1
KO icon
Coca-Cola
KO
+$27.9M
2
TMO icon
Thermo Fisher Scientific
TMO
+$9.11M
3
XOM icon
ExxonMobil
XOM
+$8.66M
4
UNH icon
UnitedHealth
UNH
+$7.74M
5
NEE icon
NextEra Energy
NEE
+$5.7M

Sector Composition

Rank Sector Weight
1 Technology 25.02%
2 Financials 10.77%
3 Healthcare 10.07%
4 Consumer Discretionary 8.12%
5 Industrials 7.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
OSPN icon
226
OneSpan
OSPN
$598M
$2.16M 0.08%
129,458
+307
+0.2% +$4.76K
MRK icon
227
Merck
MRK
$317B
$2.16M 0.08%
27,245
-1,522
-5% -$121K
PSX icon
228
Phillips 66
PSX
$82.4B
$2.16M 0.08%
18,066
+974
+6% +$109K
CLX icon
229
Clorox
CLX
$12.8B
$2.16M 0.08%
17,952
+769
+4% +$103K
RARE icon
230
Ultragenyx Pharmaceutical
RARE
$2.54B
$2.15M 0.08%
59,102
+788
+1% +$28.4K
CVS icon
231
CVS Health
CVS
$123B
$2.14M 0.08%
31,092
+1,752
+6% +$115K
ETNB
232
DELISTED
89bio
ETNB
$2.14M 0.08%
217,742
+2,905
+1% +$24.1K
TGT icon
233
Target
TGT
$66.8B
$2.11M 0.08%
21,389
+1,256
+6% +$121K
ALAB icon
234
Astera Labs
ALAB
$56.8B
$2.1M 0.08%
23,229
-488
-2% -$38.6K
IVV icon
235
iShares Core S&P 500 ETF
IVV
$897B
$2.09M 0.08%
3,645
+973
+36% +$559K
BSX icon
236
Boston Scientific
BSX
$71.4B
$2.09M 0.08%
19,422
-180
-0.9% -$18.2K
SPSC icon
237
SPS Commerce
SPSC
$2.59B
$2.08M 0.08%
15,257
+12
+0.1% +$1.66K
KALV
238
DELISTED
KalVista Pharmaceuticals
KALV
$2.06M 0.07%
182,262
+132,165
+264% +$1.62M
GH icon
239
Guardant Health
GH
$21.1B
$2.03M 0.07%
39,099
+471
+1% +$21K
ADT icon
240
ADT
ADT
$5.59B
$2.01M 0.07%
+237,425
New +$1.94M
TROW icon
241
T. Rowe Price
TROW
$24.2B
$1.99M 0.07%
20,594
+1,189
+6% +$109K
BRK.B icon
242
Berkshire Hathaway Class B
BRK.B
$1.13T
$1.95M 0.07%
4,113
+713
+21% +$362K
MFC icon
243
Manulife Financial
MFC
$74.1B
$1.94M 0.07%
60,708
+4,554
+8% +$140K
GS icon
244
Goldman Sachs
GS
$301B
$1.94M 0.07%
2,735
-1,533
-36% -$888K
ATEC icon
245
Alphatec Holdings
ATEC
$1.42B
$1.93M 0.07%
173,945
+2,325
+1% +$26.7K
LIN icon
246
Linde
LIN
$226B
$1.89M 0.07%
+4,034
New +$1.84M
MKC icon
247
McCormick & Company Non-Voting
MKC
$14.1B
$1.89M 0.07%
24,962
-499
-2% -$37.4K
FE icon
248
FirstEnergy
FE
$27.4B
$1.89M 0.07%
46,892
+2,690
+6% +$111K
EEM icon
249
iShares MSCI Emerging Markets ETF
EEM
$29.2B
$1.88M 0.07%
39,000
– –
SPSM icon
250
State Street SPDR Portfolio S&P 600 Small Cap ETF
SPSM
$17.3B
$1.86M 0.07%
43,671
– –
8 9
10
11 12

Similar funds

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
RMCM
Reynders McVeigh Capital Management Boston, Massachusetts $1.98B AUM 23.37% 1-Year Est. Return
FC
Finepoint Capital Boston, Massachusetts $1.95B AUM 45.61% 1-Year Est. Return
SC
Syon Capital San Francisco, California $1.99B AUM 22.67% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
BC
Blackhill Capital Morristown, New Jersey $1.94B AUM 18.09% 1-Year Est. Return

F/M Investments's Q2 2025 Portfolio in Review

As of Q2 2025, F/M Investments held 425 positions worth $2.75B, up 9.7% from $2.51B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

F/M Investments's Q2 2025 filing shows 34 new, 204 increased, 126 reduced and 25 closed positions. Its largest new stake was F/m Ultrashort Treasury Inflation-Protected Security (TIPS) ETF: 197,898 shares worth $9.91M. The largest sale was Coca-Cola, an estimated $27.9M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 22% a quarter earlier, followed by Financials and Healthcare.

  • F/M Investments's largest Q2 2025 buy was F/m Ultrashort Treasury Inflation-Protected Security (TIPS) ETF: 197,898 shares worth $9.91M.
  • F/M Investments added most to F/m US Treasury 3 Month Bill Fund in Q2 2025, an estimated $12M increase.
  • F/M Investments's biggest Q2 2025 reduction was Coca-Cola, cutting an estimated $27.9M.
  • F/M Investments fully exited Thermo Fisher Scientific in Q2 2025, selling an estimated $9.11M.
  • F/M Investments's ten largest holdings make up 34% of its $2.75B portfolio in Q2 2025.
  • F/M Investments opened 34 new positions and closed 25 in Q2 2025.
  • F/M Investments's portfolio value rose 9.7% quarter-over-quarter to $2.75B.

Based on F/M Investments's 13F filing for Q2 2025, filed 13 Aug 2025.